InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
nowwhat2 PremiumMember
11/27/19 12:47 PM
profile icon
Jiminy Cricket Free
10/14/19 5:26 PM
profile icon
Watkins Free
07/24/19 9:38 PM
profile icon
Renee PremiumMember
06/25/19 5:34 PM
profile icon
420man Free
06/25/19 2:32 PM
profile icon
CannabisPower Terminated
06/21/19 4:22 PM
profile icon
nukeemaway Free
05/29/19 9:10 AM
profile icon
Jiminy Cricket Free
05/17/19 11:40 AM
profile icon
TeddyCaswell Free
05/17/19 10:40 AM
profile icon
TeddyCaswell Free
05/06/19 9:39 PM
profile icon
TeddyCaswell Free
05/05/19 10:48 AM
profile icon
TeddyCaswell Free
05/01/19 10:46 AM
profile icon
Jiminy Cricket Free
04/08/19 2:54 PM
profile icon
atlass Free
04/03/19 8:45 AM
profile icon
JayBPee Free
04/02/19 6:50 AM
profile icon
Popeye Free
03/30/19 9:33 AM
profile icon
Bigpapapx Free
03/29/19 9:27 AM
profile icon
Popeye Free
03/28/19 8:16 PM
profile icon
LorentzFactor Free
03/27/19 9:18 PM
profile icon
LorentzFactor Free
03/27/19 9:17 PM
profile icon
Bigpapapx Free
03/27/19 6:54 PM
profile icon
Bigpapapx Free
03/27/19 9:36 AM
profile icon
stkmktgremlin Free
03/26/19 7:29 PM
profile icon
fausst Free
03/26/19 4:38 PM
profile icon
Whtucker Free
03/26/19 2:31 PM
profile icon
ThatGuyisMe Free
03/26/19 1:23 PM
profile icon
Jiminy Cricket Free
03/26/19 12:45 PM
profile icon
PenyStockLover Free
03/26/19 10:11 AM
profile icon
trubach Free
03/26/19 9:44 AM
profile icon
Bigpapapx Free
03/26/19 9:31 AM
profile icon
Jiminy Cricket Free
03/26/19 8:32 AM
profile icon
Bigpapapx Free
03/25/19 9:43 PM
profile icon
RotanQ Free
03/25/19 9:39 PM
profile icon
Bigpapapx Free
03/25/19 9:34 PM
profile icon
PenyStockLover Free
03/25/19 10:49 AM
profile icon
Jiminy Cricket Free
03/13/19 10:35 AM
profile icon
Popeye Free
03/12/19 3:30 PM
profile icon
biotech_moose1 Free
03/05/19 4:59 PM
profile icon
Popeye Free
03/05/19 10:45 AM
profile icon
Jiminy Cricket Free
03/05/19 10:02 AM
profile icon
nsomniyak PremiumMember
03/05/19 9:56 AM
profile icon
Jiminy Cricket Free
03/05/19 9:37 AM
profile icon
PenyStockLover Free
03/05/19 9:27 AM
profile icon
PenyStockLover Free
03/05/19 9:19 AM

Pernix Therapeutics Holdings Inc. (fka PTXTQ) RSS Feed

Followers
122
Posters
359
Posts (Today)
0
Posts (Total)
5959
Created
03/25/12
Type
Free
Moderators
Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and pain management, and has an interest in expanding into additional specialty segments. The Company promotes its branded products to physicians through its two Pernix sales forces and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, LLC and Cypress Pharmaceutical, Inc.
 
    



 
 
 


 

PRESS RELEASES (Investor Presentation located Here)


July 7, 2016  Pernix Therapeutics Announces Restructuring  of Sales Force and Operations
June 16, 2016  Pernix Therapeutics Announces Positive Phase IV Results of Silenor® vs. Zolpidem Head-to-Head Arousability Study
May 25, 2016  Pernix Therapeutics Announces the Issuance of Three New Orange Book Patents for Zohydro® ER with BeadTek™
May 11, 2016  Pernix Therapeutics Announces CEO Transition
May 9, 2016  Pernix Therapeutics Overcomes Challenge to Treximet® ‘183 Patent
May 5, 2016  Pernix Therapeutics Reports First Quarter 2016 Financial Results and Business Update
April 28, 2016  Pernix Therapeutics to Report First Quarter 2016 Financial Results on Thursday, May 5, 2016
March 10, 2016  Pernix Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Business Update
March 2, 2016  Pernix Therapeutics Files Citizen Petition Following Issuance of U.S. Patent Number 9,265,760 (‘760 Patent) Covering Safety Information Related to Dosing Patients with Zohydro ER® with BeadTek™ CII
February 24, 2016  Pernix Therapeutics to Report Fourth Quarter and Full-Year 2015 Financial Results on Thursday, March 10, 2016
February 23, 2016  Pernix Therapeutics Announces the Issuance of New Orange Book Patent for Zohydro® ER With BeadTek™ CII
UPDATED 7/7/2016
Board Info
Posts Today
0
Posts (Total)
5959
Posters
359
Moderators
New Post